Diabetes insipidus (DI) is a condition where water in the body is improperly removed from the circulatory system by the kidneys.
There are 2 forms of DI:
Antidiuretic hormone (ADH) controls the amount of water reabsorbed by the kidneys. ADH is made in the hypothalamus of the brain. The pituitary gland, at the base of the brain, stores and releases ADH.
Central DI occurs when the hypothalamus does not make enough ADH.
NDI occurs when the kidneys do not respond to ADH.
Some diabetes insipidus is caused by genetic problems. Most others develop after an injury, illness, or exposure to a medication.
Factors that may increase your risk of DI include:
Symptoms may include:
You will be asked about your symptoms and medical history. A physical exam may be done.
Your bodily fluids may be tested. This can be done with:
Your doctor will work with you to address the underlying cause.
Treatment may include:
American Diabetes Association
Nephrogenic Diabetes Insipidus Foundation
Canadian Diabetes Association
Central diabetes insipidus. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T115774/Central-diabetes-insipidus. Updated June 7, 2017. Accessed August 24, 2017.
Diabetes insipidus. National Institute of Diabetes and Digestive and Kidney Diseases website. Available at: https://www.niddk.nih.gov/health-information/kidney-disease/diabetes-insipidus. Updated January 13, 2014. Accessed August 24, 2017.
Jain V. Ravindranath A. Diabetes insipidus in children. J Pediatr Endocrinol Metab. 2016 Jan;29(1):39-45. Available at: https://www.degruyter.com/view/j/jpem.2016.29.issue-1/jpem-2014-0518/jpem-2014-0518.xml. Accessed September 19, 2017.
Lu H. Diabetes insipidus. Adv Exp Med Biol. 2017;969:213-225.
Nephrogenic diabetes insipidus. EBSCO DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116727/Nephrogenic-diabetes-insipidus. Updated June 7, 2017. Accessed August 24, 2017.
Rivkees SA, Dunbar N, Wilson TA. The management of central diabetes insipidus in infancy: desmopressin, low renal solue load formula, thazide diuretics. J Pediatr Endocrinol Metab. 2007;20(4):459-469.
Toumba M, Stanhope R. Morbidity and mortality associated with desmopressin treatment. Pediatr Endocrinol Metab. 2006;19(3):197-201.
Last reviewed September 2017 by EBSCO Medical Review Board Michael Woods, MD, FAAP
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.